SCYOVA 240 mg/ml + 12 mg/ml, solution for infusion 7 bottles of 10 ml
Active ingredients: FOSCARBIDOPA, FOSLÉVODOPA
Commercialized according to BDPMDispensing in France: Prescription only
Solution for infusion7 bottles of 10 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SCYOVA 240 mg/mL + 12 mg/mL, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- sous-cutanée
- Presentation description
- 7 flacons en verre de 10 mL
- Marketing authorisation holder
- ABBVIE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 28 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67588742CIP73027908CIP133400930279083Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FOSLÉVODOPAsolution | 240 mg · 1 mL de solution | SA |
| FOSCARBIDOPAsolution | 12 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.